… of tumour characteristics associated with tumour response and outcome is of great clinical
… neoadjuvant chemotherapy. Tumour samples were taken prior to and after chemotherapy. …

… phase II trials using neoadjuvant chemotherapy to treat patients … evaluate whether response
to neoadjuvant chemotherapy is … The outcome of such trials will define whether neoadjuvant …

… to determine the response to neoadjuvant chemotherapy and survival outcomes of
patients with resectable CLM, by examining the response to neoadjuvant chemotherapy (radiological …

… pCR and survival outcomes in young … neoadjuvant chemotherapy (NAC) for stage II–III
invasive breast cancer between 1998 and 2014 at Massachusetts General Hospital. Outcomes …

… treatment, and we notably found this did not further improve outcomes. The results of this
comprehensive meta-analysis overall suggest pCR is a strong surrogate endpoint for TNBC …

… treated with neoadjuvant chemotherapy for locally advanced breast cancers found little
evidence that measurable clinical or pathologic changes attributable to chemotherapy predicted …

… or pathologic responses to neoadjuvant chemotherapy had … with pCR after neoadjuvant
chemotherapy defined patients with … a more pronounced response to neoadjuvant chemotherapy …

… Given mounting evidence that breast cancer subtypes differ in their short (pCR 11 )
responses and long-term outcome 12 to cytotoxic treatment, our post hoc statistical approach …

… A pathologic complete response (pCR) can sometimes be induced by intensive or long-term
neoadjuvant chemotherapy (NAC). This prognostic research study based on a systematic …

… We have identified AAGAB as a novel on-treatment biomarker for accurate prediction of
pCR and outcome in patients treated with neoadjuvant chemotherapy. A semi-supervised …